aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
0.4606
-0.0023 (-0.50%)
Jun 18, 2026, 1:14 PM EDT - Market open
aTyr Pharma Market Cap
aTyr Pharma has a market cap or net worth of $45.16 million as of June 18, 2026. Its market cap has decreased by -90.13% in one year.
Market Cap
45.16M
Enterprise Value
-9.43M
1-Year Change
-90.13%
Ranking
Category
Stock Price
$0.46
Market Cap Chart
Since May 7, 2015, aTyr Pharma's market cap has decreased from $337.10M to $45.16M, a decrease of -86.60%. That is a compound annual growth rate of -16.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 45.16M | -41.12% |
| Dec 31, 2025 | 76.70M | -74.76% |
| Dec 31, 2024 | 303.90M | 267.92% |
| Dec 29, 2023 | 82.60M | 30.08% |
| Dec 30, 2022 | 63.50M | -69.41% |
| Dec 31, 2021 | 207.60M | 428.24% |
| Dec 31, 2020 | 39.30M | 142.59% |
| Dec 31, 2019 | 16.20M | 8.72% |
| Dec 31, 2018 | 14.90M | -85.70% |
| Dec 29, 2017 | 104.20M | 104.31% |
| Dec 30, 2016 | 51.00M | -78.06% |
| Dec 31, 2015 | 232.50M | -31.03% |
| May 7, 2015 | 337.10M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immutep | 50.01M |
| Dogwood Therapeutics | 49.77M |
| Lantern Pharma | 49.63M |
| Mereo BioPharma Group | 49.48M |
| Actuate Therapeutics | 49.05M |
| Veru Inc. | 47.99M |
| Metagenomi Therapeutics | 44.42M |
| Estrella Immunopharma | 43.46M |